These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 21704600)

  • 1. Formulation and optimization of nanotransfersomes using experimental design technique for accentuated transdermal delivery of valsartan.
    Ahad A; Aqil M; Kohli K; Sultana Y; Mujeeb M; Ali A
    Nanomedicine; 2012 Feb; 8(2):237-49. PubMed ID: 21704600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced transdermal delivery of an anti-hypertensive agent via nanoethosomes: statistical optimization, characterization and pharmacokinetic assessment.
    Ahad A; Aqil M; Kohli K; Sultana Y; Mujeeb M
    Int J Pharm; 2013 Feb; 443(1-2):26-38. PubMed ID: 23313344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of antihypertensive activity of carbopol valsartan transdermal gel containing 1,8-cineole.
    Ahad A; Aqil M; Ali A
    Int J Biol Macromol; 2014 Mar; 64():144-9. PubMed ID: 24296403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and development of ethosomal transdermal drug delivery system of valsartan with preclinical assessment in Wistar albino rats.
    Bhosale SS; Avachat AM
    J Liposome Res; 2013 Jun; 23(2):119-25. PubMed ID: 23324030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, formulation and optimization of valsartan transdermal gel containing iso-eucalyptol as novel permeation enhancer: preclinical assessment of pharmacokinetics in Wistar albino rats.
    Ahad A; Aqil M; Kohli K; Sultana Y; Mujeeb M
    Expert Opin Drug Deliv; 2014 Aug; 11(8):1149-62. PubMed ID: 24830648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental design and optimization of raloxifene hydrochloride loaded nanotransfersomes for transdermal application.
    Mahmood S; Taher M; Mandal UK
    Int J Nanomedicine; 2014; 9():4331-46. PubMed ID: 25246789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elastic liposomes mediated transdermal delivery of an anti-hypertensive agent: propranolol hydrochloride.
    Mishra D; Garg M; Dubey V; Jain S; Jain NK
    J Pharm Sci; 2007 Jan; 96(1):145-55. PubMed ID: 16960826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced transdermal delivery of acyclovir sodium via elastic liposomes.
    Jain SK; Gupta Y; Jain A; Rai K
    Drug Deliv; 2008; 15(3):141-7. PubMed ID: 18379926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, formulation and optimization of novel soft nano-carriers for transdermal olmesartan medoxomil delivery: In vitro characterization and in vivo pharmacokinetic assessment.
    Kamran M; Ahad A; Aqil M; Imam SS; Sultana Y; Ali A
    Int J Pharm; 2016 May; 505(1-2):147-58. PubMed ID: 27005906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Invasomes of isradipine for enhanced transdermal delivery against hypertension: formulation, characterization, and in vivo pharmacodynamic study.
    Qadri GR; Ahad A; Aqil M; Imam SS; Ali A
    Artif Cells Nanomed Biotechnol; 2017 Feb; 45(1):139-145. PubMed ID: 26829018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Valsartan/hydrochlorothiazide: a review of its use in the management of hypertension.
    Wagstaff AJ
    Drugs; 2006; 66(14):1881-901. PubMed ID: 17040120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formulation and optimization of lacidipine loaded niosomal gel for transdermal delivery: In-vitro characterization and in-vivo activity.
    Qumbar M; Ameeduzzafar ; Imam SS; Ali J; Ahmad J; Ali A
    Biomed Pharmacother; 2017 Sep; 93():255-266. PubMed ID: 28738502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. VALUE in hypertension treatment.
    Berk BC; Bisognano JD
    Curr Hypertens Rep; 2004 Dec; 6(6):411-3. PubMed ID: 15527682
    [No Abstract]   [Full Text] [Related]  

  • 14. New-onset diabetes, antihypertensive treatment, and outcome.
    Verdecchia P; Angeli F; Reboldi G
    Hypertension; 2007 Sep; 50(3):459-60. PubMed ID: 17679646
    [No Abstract]   [Full Text] [Related]  

  • 15. [Fast-acting sartan. High blood pressure therapy without long waiting time].
    MMW Fortschr Med; 2003 Jun; 145(24):55. PubMed ID: 12866306
    [No Abstract]   [Full Text] [Related]  

  • 16. Assessment of the optimal daily dose of valsartan in patients with hypertension, heart failure, or both.
    Verdecchia P; Angeli F
    Clin Ther; 2004 Apr; 26(4):460-72. PubMed ID: 15189744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microemulsion Transdermal Formulation for Simultaneous Delivery of Valsartan and Nifedipine: Formulation by Design.
    Sood J; Sapra B; Tiwary AK
    AAPS PharmSciTech; 2017 Aug; 18(6):1901-1916. PubMed ID: 27858253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of 24-h blood pressure profiles: a new target for treatment?
    Palatini P; Parati G
    J Hypertens; 2005 Oct; 23(10):1799-801. PubMed ID: 16148601
    [No Abstract]   [Full Text] [Related]  

  • 19. Development and optimization of nanoemulsion based gel for enhanced transdermal delivery of nitrendipine using box-behnken statistical design.
    Sharma A; Singh AP; Harikumar SL
    Drug Dev Ind Pharm; 2020 Feb; 46(2):329-342. PubMed ID: 31976777
    [No Abstract]   [Full Text] [Related]  

  • 20. Formulation, characterization and optimization of valsartan self-microemulsifying drug delivery system using statistical design of experiment.
    Poudel BK; Marasini N; Tran TH; Choi HG; Yong CS; Kim JO
    Chem Pharm Bull (Tokyo); 2012; 60(11):1409-18. PubMed ID: 23124565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.